Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
Chubb
Cerilliant
Chinese Patent Office
Accenture
McKinsey
McKesson
Express Scripts

Generated: June 18, 2018

DrugPatentWatch Database Preview

SUPRANE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Suprane, and when can generic versions of Suprane launch?

Suprane is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in SUPRANE is desflurane. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the desflurane profile page.
Drug patent expirations by year for SUPRANE
Pharmacology for SUPRANE
Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Synonyms for SUPRANE
(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
1-(difluoromethoxy)-1,2,2,2-tetrafluoroethane
1,1,1,2-tetrafluoro-2-(difluoromethoxy)ethane
1,2,2,2-Tetrafluoroethyl difluoromethyl ether
2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane
57041-67-5
5829AE
AC1L274J
AC1Q4ICY
AK129759
AKOS006228397
C-04968
C07519
C3H2F6O
CC-26789
CHEBI:4445
CHEMBL1200733
CHF2OCHFCF3
CTK5A6200
D00546
D0H4GN
DB01189
Desfluran-O
DESFLURANE
Desflurane (JAN/USP/INN)
Desflurane [USAN:INN]
Desflurane [USAN:USP:INN:BAN]
Desflurano
Desflurano [INN-Spanish]
Desfluranum
Desfluranum [INN-Latin]
difluoromethyl 1,2,2,2-tetrafluoroethyl ether
DPYMFVXJLLWWEU-UHFFFAOYSA-N
Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-
Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-, (+-)-
Ethane,2-(difluoromethoxy)-1,1,1,2-tetrafluoro-
FCH917950
FT-0624525
GTPL7156
I 653
I-653
I14-29587
I653
KB-224010
LS-65505
MFCD00236716
MolPort-001-776-387
OR002154
OR168813
PC6781E
r-e 236ea1
SBB088129
SC-62385
SCHEMBL62917
Suprane (TN)
TR-019952
VZ31862
ZX-AP005907

US Patents and Regulatory Information for SUPRANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare SUPRANE desflurane LIQUID;INHALATION 020118-001 Sep 18, 1992 AN RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for SUPRANE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare SUPRANE desflurane LIQUID;INHALATION 020118-001 Sep 18, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare SUPRANE desflurane LIQUID;INHALATION 020118-001 Sep 18, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for SUPRANE
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Inhalation 99.90% ➤ Subscribe 2008-09-11

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Argus Health
Cantor Fitzgerald
Baxter
Chinese Patent Office
Accenture
Federal Trade Commission
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.